Multiple Sclerosis Journal - Experimental, Translational and Clinical
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.0 | Q3 | 36.8% | 0.665 | Q2 | 71.1% |
| 2024 | 2.3 | Q3 | 46.0% | 0.738 | Q2 | 75.3% |
| 2023 | 2.5 | Q2 | 64.4% | 0.959 | Q2 | 84.5% |
| 2022 | 2.8 | 62.2% | 0.714 | Q2 | 77.3% | |
| 2021 | — | 43.8% | 0.849 | Q2 | 82.7% | |
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2055-2173
region
Western Europe
coverage
2015-2026